Post-IPO Equity Therapeutics Companies

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for osteosarcoma.

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Medical Aesthetics, Longevity, Anti-Aging, Regenerative Medicine, Wound Care, Human Collagen

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.

Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.

Medicenna is a clinical stage, privately held, immuno-oncology company.

ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.